153 results
Page 2 of 8
8-K
EX-3.1
1hx5x56bslpxxces7bn2
15 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:12pm
8-K
y2u jjjozxa
25 Jan 24
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
7:03am
8-K
EX-99.1
l8zeu3l
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-99.1
pwcpzy1iiy8 ue5gk3h
6 Nov 23
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
9:04am
8-K
EX-99.2
o9dy0d6s
6 Nov 23
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
9:04am
8-K
df4e1tditr93bh0 b3
6 Oct 23
Departure of Directors or Certain Officers
5:00pm
8-K
EX-99.1
039yvz5vt6er 1o3se
13 Sep 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
32xm7
9 Aug 23
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
7l7ltp
9 Aug 23
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
7:03am
8-K
EX-1.1
eo1 f0ndfx0
15 Jun 23
Other Events
4:23pm
424B5
9u0da4rb9x
15 Jun 23
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
02e6c09vxyu ij
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
EX-99.2
y6d6tafm48986l19 zg3
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
EX-99.3
qj75dmoefh
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
wtg7ic1bz85
26 May 23
Regulation FD Disclosure
12:38pm
8-K
EX-99.1
qer1xcs4
26 May 23
Regulation FD Disclosure
12:38pm